Atrial Fibrillation After Respiratory Syncytial Virus Vaccination Among Older Adults
RSV vaccine clinical trials reported higher frequencies of atrial fibrillation in intervention groups compared to control. In this large, population-based, propensity-matched study, we found RSV vaccine was not associated with increased risk of new-onset or recurrent atrial fibrillation within 1-42 days compared to influenza or Tdap vaccines.
Authors
- Scott Johns (ORCID: https://orcid.org/0000-0002-5668-7564)
- Thomas Martin (ORCID: https://orcid.org/0000-0002-5935-2348)
- David C. Kaelber (ORCID: https://orcid.org/0000-0001-7855-9515)
- Sanjay R. Mehta (ORCID: https://orcid.org/0000-0002-2028-8158)
- Morgan Birabaharan
Institutions
- San Francisco VA Medical Center (US)
- University of California San Diego (US)
- Case Western Reserve University (US)
Publication Details
- Journal
- Clinical Infectious Diseases
- Published
- 2024-12-26
- DOI
- https://doi.org/10.1093/cid/ciae649
- Citations
- 5
- Primary Topic
- Viral Infections and Immunology Research
- Type
- article
- Field-Weighted Citation Impact
- 2.01
Funders
- National Institutes of Health
- Clinical and Translational Science Collaborative of Cleveland, School of Medicine, Case Western Reserve University